Literature DB >> 10674372

Immunology of the hair follicle: a short journey into terra incognita.

R Paus1, T Christoph, S Müller-Röver.   

Abstract

This paper delineates briefly why the immunology of the hair follicle matters (e.g., anti-infection defense, hair growth control by immunomodulatory agents, sequestration of follicular autoantigens), and which open key questions await clarification. We then focus on the murine hair follicle immune system (HIS) and its immune privilege. We show how the murine HIS is gradually constructed during hair follicle morphogenesis, and how it is transformed during hair follicle cycling. Key characteristics of the HIS are summarized, such as the absence of MHC class I expression in the anagen hair bulb and the very restricted distribution of antigen-presenting cells and intraepithelial T cells to the distal outer root sheath, which also expresses nonclassical MHC class Ib molecules. The interconnections between the HIS and the skin immune system (SIS) and potential hair growth-modulatory roles of mast cells and macrophages are addressed, and very recent findings on the human HIS are summarized. The paper closes by sketching immunobiologic, clinical, and pharmacologic perspectives in trichoimmunology that deserve the attention of immunologists, dermatologists, and hair biologists alike.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10674372     DOI: 10.1038/sj.jidsp.5640217

Source DB:  PubMed          Journal:  J Investig Dermatol Symp Proc        ISSN: 1087-0024


  18 in total

1.  Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model.

Authors:  Taisuke Ito; Natsuho Ito; Albrecht Bettermann; Yoshiki Tokura; Masahiro Takigawa; Ralf Paus
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

2.  Review.

Authors:  Gloria Taliani; Elisa Biliotti
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-08

Review 3.  Lymphocytes, neuropeptides, and genes involved in alopecia areata.

Authors:  Amos Gilhar; Ralf Paus; Richard S Kalish
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

4.  Effects of the Lexington LaserComb on hair regrowth in the C3H/HeJ mouse model of alopecia areata.

Authors:  Tongyu Cao Wikramanayake; Rosa Rodriguez; Sonal Choudhary; Lucia M Mauro; Keyvan Nouri; Lawrence A Schachner; Joaquin J Jimenez
Journal:  Lasers Med Sci       Date:  2011-07-09       Impact factor: 3.161

5.  Immune-mediated loss of transgene expression in skin: implications for cutaneous gene therapy.

Authors:  Soosan Ghazizadeh; Richard S Kalish; Lorne B Taichman
Journal:  Mol Ther       Date:  2003-03       Impact factor: 11.454

6.  Loss of Gata6 causes dilation of the hair follicle canal and sebaceous duct.

Authors:  Jacob B Swanson; Alicia N Vagnozzi; Natalia A Veniaminova; Sunny Y Wong
Journal:  Exp Dermatol       Date:  2018-09-11       Impact factor: 3.960

7.  Reduction in Human Epidermal Langerhans Cells with Age Is Associated with Decline in CXCL14-Mediated Recruitment of CD14+ Monocytes.

Authors:  Tatsuya Hasegawa; Zhaoyi Feng; Zhiyu Yan; Kenneth H Ngo; Junichi Hosoi; Shadmehr Demehri
Journal:  J Invest Dermatol       Date:  2019-12-25       Impact factor: 8.551

Review 8.  What causes alopecia areata?

Authors:  K J McElwee; A Gilhar; D J Tobin; Y Ramot; J P Sundberg; M Nakamura; M Bertolini; S Inui; Y Tokura; L E King; B Duque-Estrada; A Tosti; A Keren; S Itami; Y Shoenfeld; A Zlotogorski; R Paus
Journal:  Exp Dermatol       Date:  2013-09       Impact factor: 3.960

9.  Analysis of serum zinc and copper concentrations in hair loss.

Authors:  Min Seong Kil; Chul Woo Kim; Sang Seok Kim
Journal:  Ann Dermatol       Date:  2013-11-30       Impact factor: 1.444

10.  Increased expression of Cxcr3 and its ligands, Cxcl9 and Cxcl10, during the development of alopecia areata in the mouse.

Authors:  Caroline G McPhee; F Jason Duncan; Kathleen A Silva; Lloyd E King; Harm Hogenesch; Derry C Roopenian; Helen B Everts; John P Sundberg
Journal:  J Invest Dermatol       Date:  2012-02-23       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.